Identification of TP53 mutation-associated prognostic genes and investigation of the immune cell infiltration in patients with hepatocellular carcinoma

被引:0
作者
Yang, Qijun [1 ]
Gao, Lianke [3 ]
Xu, Yuhan [2 ]
Cao, Gaoquan [4 ]
He, Yingcheng
Zhang, Wenyige [2 ]
Zhang, Xue [2 ]
Wu, Chengfeng [5 ]
Liao, Kaili [1 ]
Wang, Xiaozhong [1 ]
机构
[1] Nanchang Univ, Affiliated Hosp 2, Dept Clin Lab, Nanchang 330006, Jiangxi, Peoples R China
[2] Nanchang Univ, Queen Mary Coll, Nanchang 330031, Jiangxi, Peoples R China
[3] Nanchang Univ, Adv Mfg Coll, Nanchang 330031, Jiangxi, Peoples R China
[4] Nanchang Univ, Clin Sch 4, South Rd Bayi Sq, Nanchang 330031, Jiangxi, Peoples R China
[5] Nanchang Univ, Affiliated Hosp 2, Dept Vasc Surg, Nanchang 330006, Jiangxi, Peoples R China
基金
中国国家自然科学基金;
关键词
D O I
10.1016/j.gendis.2023.03.020
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
[No abstract available]
引用
收藏
页码:520 / 523
页数:4
相关论文
共 50 条
[11]   Overexpression of TP53 mutation-associated microRNA-182 promotes tumor cell proliferation and migration in head and neck squamous cell carcinoma [J].
Wang, Li ;
Jiang, Haihua ;
Li, Wencai ;
Jia, Chuanliang ;
Zhang, Hua ;
Sun, Yan ;
Chen, Xiumei ;
Song, Xicheng .
ARCHIVES OF ORAL BIOLOGY, 2017, 73 :105-112
[12]   Mutations in TP53 and PIK3CA genes in hepatocellular carcinoma patients are associated with chronic Schistosomiasis [J].
AlGabbani, Qwait .
SAUDI JOURNAL OF BIOLOGICAL SCIENCES, 2022, 29 (02) :848-853
[13]   Development and validation of a TP53-associated immune prognostic model for hepatocellular carcinoma [J].
Long, Junyu ;
Wang, Anqiang ;
Bai, Yi ;
Lin, Jianzhen ;
Yang, Xu ;
Wang, Dongxu ;
Yang, Xiaobo ;
Jiang, Yan ;
Zhao, Haitao .
EBIOMEDICINE, 2019, 42 :363-374
[14]   Rhabdomyosarcoma-Associated Renal Cell Carcinoma: A Link with Constitutional TP53 Mutation [J].
Curry, Sarah ;
Ibrahim, Fadi ;
Grehan, David ;
Mcdermott, Michael ;
Capra, Michael ;
Betts, David ;
O'Sullivan, Maureen .
PEDIATRIC AND DEVELOPMENTAL PATHOLOGY, 2011, 14 (03) :248-251
[15]   Effect of TP53 mutation, expression and polymorphism on the survival, immune infiltration and ferroptosis in patients with prostate cancer [J].
Wen, Gui-Min ;
Zhao, Zhen-Ying ;
Zheng, Xiao-Hui ;
Liu, Da-Hua ;
Xia, Pu .
ONCOLOGY LETTERS, 2025, 30 (03)
[16]   Association between TP53 R249S mutation and polymorphisms in TP53 intron 1 in hepatocellular carcinoma [J].
Ortiz-Cuaran, Sandra ;
Cox, David ;
Villar, Stephanie ;
Friesen, Marlin D. ;
Durand, Geoffroy ;
Chabrier, Amelie ;
Khuhaprema, Thiravud ;
Sangrajrang, Suleeporn ;
Ognjanovic, Simona ;
Groopman, John D. ;
Hainaut, Pierre ;
Le Calvez-Kelm, Florence .
GENES CHROMOSOMES & CANCER, 2013, 52 (10) :912-919
[17]   Targeted Combination Therapies: A New Frontier in the Treatment of TP53 and KRAS Mutation-Associated Cancers [J].
Kargbo, Robert B. .
ACS MEDICINAL CHEMISTRY LETTERS, 2023, 15 (01) :15-16
[18]   Correlation of TP53 mutations with HCV positivity in hepatocarcinogenesis: Identification of a novel TP53 microindel in hepatocellular carcinoma with HCV infection [J].
Long, Jiang ;
Wang, Yan ;
Li, Man ;
Tong, Wei-Min ;
Jia, Ji-Dong ;
Huang, Jian .
ONCOLOGY REPORTS, 2013, 30 (01) :119-124
[19]   The prognostic role of a novel TP53 mutation classifier in resectable esophageal squamous-cell carcinoma [J].
Su, Dan ;
Huang, Minran ;
Jin, Jiaoyue ;
Wu, Yingxue ;
Ying, Lisa ;
Zhang, Fanrong ;
Chen, Kaiyan .
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
[20]   TP53 mutation is not an independent prognostic factor in patients with mantle cell lymphoma at advanced stage [J].
Hua-Jie Dong ;
Li-Tao Zhou ;
Cheng Fang ;
Lei Fan ;
Dan-Xia Zhu ;
Yin-Hua Wang ;
Jian-Yong Li ;
Wei Xu .
Medical Oncology, 2012, 29 :2166-2173